Following peripheral nerve injury, impaired neurons release this molecule into the synaptic environment, acting on IGF1R on DRG neurons and consequently mediating an enhancement of protein kinase C alpha (PKCα)-dependent T-type calcium currents to increase pain. The gene discussed is PRKCA; the disease is peripheral nerve injury.